Selective isonitrile inhibitors of cytochrome p450 subtypes
AssigneeBrandeis University
InventorsThomas Charles Pochapsky, Nathan Ross Wong, Reethy Sundar
Life of this patent
Estimating the term…
Loading patent…
AssigneeBrandeis University
InventorsThomas Charles Pochapsky, Nathan Ross Wong, Reethy Sundar
Estimating the term…
Described herein are steroid or steroid-like compounds including at least one isonitrile group and which inhibit the activity of a cytochrome P450 enzyme, as well as compositions including the compounds. Also included are methods of inhibiting activity of a cytochrome P450 in a subject having a steroid-responsive cancer, a Mycobacterium tuberculosis infection, a fungal infection, or a trypanosome infection, the method comprising administering to the subject the compound including at least one isonitrile group or a pharmaceutically acceptable salt thereof, in an amount effective to inhibit the CYP activity in the subject.
A compound represented by Formula 1 and comprising at least one isonitrile (—NC), or a pharmaceutically acceptable salt thereof
(canceled)
(canceled)
8-11. (canceled)
(canceled)
(canceled)
23-36. (canceled)
A method providing a chemical structure of an isonitrile inhibitor of a cytochrome P450 comprising (a) oxidizing a parent compound with a cytochrome P450 to provide an oxidation product comprising an oxidized functional group;
Dependencies are inferred from the claim text.